nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—CA6—saliva-secreting gland—thyroid cancer	0.147	0.184	CbGeAlD
Sulpiride—CA6—head—thyroid cancer	0.0795	0.0999	CbGeAlD
Sulpiride—CA12—trachea—thyroid cancer	0.076	0.0954	CbGeAlD
Sulpiride—DRD3—head—thyroid cancer	0.0684	0.0859	CbGeAlD
Sulpiride—CA2—neck—thyroid cancer	0.0648	0.0814	CbGeAlD
Sulpiride—CA12—head—thyroid cancer	0.0533	0.067	CbGeAlD
Sulpiride—CA2—saliva-secreting gland—thyroid cancer	0.0506	0.0635	CbGeAlD
Sulpiride—CA2—trachea—thyroid cancer	0.039	0.049	CbGeAlD
Sulpiride—BCHE—trachea—thyroid cancer	0.0374	0.0469	CbGeAlD
Sulpiride—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EPO—thyroid cancer	0.0315	0.155	CbGpPWpGaD
Sulpiride—CA2—thyroid gland—thyroid cancer	0.0309	0.0388	CbGeAlD
Sulpiride—BCHE—thyroid gland—thyroid cancer	0.0296	0.0371	CbGeAlD
Sulpiride—DRD2—head—thyroid cancer	0.0289	0.0363	CbGeAlD
Sulpiride—CA2—head—thyroid cancer	0.0274	0.0344	CbGeAlD
Sulpiride—BCHE—head—thyroid cancer	0.0262	0.0329	CbGeAlD
Sulpiride—CA2—lymph node—thyroid cancer	0.0192	0.0241	CbGeAlD
Sulpiride—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—thyroid cancer	0.0188	0.092	CbGpPWpGaD
Sulpiride—BCHE—lymph node—thyroid cancer	0.0184	0.0231	CbGeAlD
Sulpiride—CA9—Cellular response to hypoxia—EPO—thyroid cancer	0.0139	0.0683	CbGpPWpGaD
Sulpiride—CA9—Cellular response to hypoxia—HIF1A—thyroid cancer	0.00828	0.0406	CbGpPWpGaD
Sulpiride—CA9—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00816	0.04	CbGpPWpGaD
Sulpiride—CA9—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.0064	0.0314	CbGpPWpGaD
Sulpiride—CA9—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.00398	0.0195	CbGpPWpGaD
Sulpiride—CA9—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.00381	0.0187	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MINPP1—thyroid cancer	0.00314	0.0154	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—NKX2-1—thyroid cancer	0.003	0.0147	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MINPP1—thyroid cancer	0.00272	0.0133	CbGpPWpGaD
Sulpiride—CA6—Metabolism—NDUFA13—thyroid cancer	0.00267	0.0131	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CHST14—thyroid cancer	0.00251	0.0123	CbGpPWpGaD
Sulpiride—CA12—Metabolism—NDUFA13—thyroid cancer	0.00231	0.0113	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00229	0.0112	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—CALCB—thyroid cancer	0.00223	0.0109	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CHST14—thyroid cancer	0.00217	0.0107	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—EPO—thyroid cancer	0.00211	0.0104	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MINPP1—thyroid cancer	0.00208	0.0102	CbGpPWpGaD
Sulpiride—CA6—Metabolism—HPGD—thyroid cancer	0.00203	0.00994	CbGpPWpGaD
Sulpiride—CA2—Metabolism—NDUFA13—thyroid cancer	0.00177	0.00867	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MINPP1—thyroid cancer	0.00175	0.0086	CbGpPWpGaD
Sulpiride—CA12—Metabolism—HPGD—thyroid cancer	0.00175	0.0086	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—CALCB—thyroid cancer	0.0017	0.00837	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CHST14—thyroid cancer	0.00166	0.00815	CbGpPWpGaD
Sulpiride—CA9—Metabolism—NDUFA13—thyroid cancer	0.00149	0.00731	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00142	0.00697	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CHST14—thyroid cancer	0.0014	0.00687	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00135	0.00665	CbGpPWpGaD
Sulpiride—CA2—Metabolism—HPGD—thyroid cancer	0.00134	0.00657	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—SST—thyroid cancer	0.00132	0.0065	CbGpPWpGaD
Sulpiride—CA9—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.00128	0.00628	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CALCB—thyroid cancer	0.00126	0.00618	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—HIF1A—thyroid cancer	0.00126	0.00617	CbGpPWpGaD
Sulpiride—CA6—Metabolism—TPR—thyroid cancer	0.00116	0.00571	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PRKAR1A—thyroid cancer	0.00114	0.00562	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CALCB—thyroid cancer	0.00114	0.00561	CbGpPWpGaD
Sulpiride—CA9—Metabolism—HPGD—thyroid cancer	0.00113	0.00554	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.00105	0.00517	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00104	0.00509	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—TSHR—thyroid cancer	0.00103	0.00506	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—SST—thyroid cancer	0.00101	0.00497	CbGpPWpGaD
Sulpiride—CA12—Metabolism—TPR—thyroid cancer	0.00101	0.00494	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PRKAR1A—thyroid cancer	0.00099	0.00486	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MINPP1—thyroid cancer	0.000981	0.00481	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CALCB—thyroid cancer	0.000963	0.00473	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—PTCH1—thyroid cancer	0.000877	0.0043	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CALCB—thyroid cancer	0.000875	0.00429	CbGpPWpGaD
Sulpiride—CA6—Metabolism—SLC5A5—thyroid cancer	0.000871	0.00427	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NDUFA13—thyroid cancer	0.000834	0.00409	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000806	0.00396	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—SST—thyroid cancer	0.000802	0.00394	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—TSHR—thyroid cancer	0.000789	0.00387	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CHST14—thyroid cancer	0.000784	0.00385	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—CALCA—thyroid cancer	0.000772	0.00379	CbGpPWpGaD
Sulpiride—CA2—Metabolism—TPR—thyroid cancer	0.000769	0.00377	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—PPARG—thyroid cancer	0.000767	0.00376	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PRKAR1A—thyroid cancer	0.000757	0.00371	CbGpPWpGaD
Sulpiride—CA12—Metabolism—SLC5A5—thyroid cancer	0.000753	0.0037	CbGpPWpGaD
Sulpiride—CA6—Metabolism—RXRA—thyroid cancer	0.000732	0.00359	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000728	0.00357	CbGpPWpGaD
Sulpiride—BCHE—Phospholipid metabolism—PTEN—thyroid cancer	0.00069	0.00339	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CALCB—thyroid cancer	0.000675	0.00331	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—PTCH1—thyroid cancer	0.000671	0.00329	CbGpPWpGaD
Sulpiride—CA9—Metabolism—TPR—thyroid cancer	0.000648	0.00318	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TRIM33—thyroid cancer	0.00064	0.00314	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PRKAR1A—thyroid cancer	0.000638	0.00313	CbGpPWpGaD
Sulpiride—CA12—Metabolism—RXRA—thyroid cancer	0.000633	0.00311	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—HPGD—thyroid cancer	0.000632	0.0031	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—SST—thyroid cancer	0.000614	0.00301	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—CALCA—thyroid cancer	0.000591	0.0029	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—PPARG—thyroid cancer	0.000587	0.00288	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—TSHR—thyroid cancer	0.000583	0.00286	CbGpPWpGaD
Sulpiride—CA2—Metabolism—SLC5A5—thyroid cancer	0.000576	0.00283	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—BRAF—thyroid cancer	0.000558	0.00274	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—TSHR—thyroid cancer	0.000529	0.0026	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—PTEN—thyroid cancer	0.000526	0.00258	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000521	0.00256	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CALCB—thyroid cancer	0.000517	0.00254	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000513	0.00252	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—TP53—thyroid cancer	0.0005	0.00246	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TRIM33—thyroid cancer	0.00049	0.0024	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SLC5A5—thyroid cancer	0.000485	0.00238	CbGpPWpGaD
Sulpiride—CA2—Metabolism—RXRA—thyroid cancer	0.000484	0.00237	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PPARG—thyroid cancer	0.000462	0.00227	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—SST—thyroid cancer	0.000453	0.00222	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PTCH1—thyroid cancer	0.00045	0.00221	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—TSHR—thyroid cancer	0.000446	0.00219	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CALCA—thyroid cancer	0.000436	0.00214	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TCF7L1—thyroid cancer	0.000427	0.0021	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—SST—thyroid cancer	0.000412	0.00202	CbGpPWpGaD
Sulpiride—CA9—Metabolism—RXRA—thyroid cancer	0.000408	0.002	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—TSHR—thyroid cancer	0.000405	0.00199	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—PTEN—thyroid cancer	0.000402	0.00197	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PPARG—thyroid cancer	0.0004	0.00196	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000398	0.00196	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CALCA—thyroid cancer	0.000396	0.00194	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PTGS2—thyroid cancer	0.000363	0.00178	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TPR—thyroid cancer	0.000363	0.00178	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—TP53—thyroid cancer	0.000359	0.00176	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CDK1—thyroid cancer	0.000359	0.00176	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PRKAR1A—thyroid cancer	0.000357	0.00175	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—SST—thyroid cancer	0.000347	0.0017	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PTCH1—thyroid cancer	0.000344	0.00169	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000335	0.00164	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CALCA—thyroid cancer	0.000334	0.00164	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TCF7L1—thyroid cancer	0.000327	0.0016	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000324	0.00159	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PTEN—thyroid cancer	0.000317	0.00156	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—SST—thyroid cancer	0.000315	0.00155	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PTGS2—thyroid cancer	0.000314	0.00154	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TSHR—thyroid cancer	0.000313	0.00153	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PRKAR1A—thyroid cancer	0.000308	0.00151	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PPARG—thyroid cancer	0.000305	0.0015	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CALCA—thyroid cancer	0.000303	0.00149	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MEN1—thyroid cancer	0.000294	0.00144	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—TP53—thyroid cancer	0.000275	0.00135	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CDK1—thyroid cancer	0.000274	0.00135	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PTEN—thyroid cancer	0.000274	0.00135	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC5A5—thyroid cancer	0.000272	0.00133	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTCH1—thyroid cancer	0.000266	0.0013	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PPARG—thyroid cancer	0.000257	0.00126	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—HRAS—thyroid cancer	0.000256	0.00126	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000255	0.00125	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SST—thyroid cancer	0.000243	0.00119	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PTGS2—thyroid cancer	0.00024	0.00118	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TSHR—thyroid cancer	0.000239	0.00117	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000235	0.00116	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CALCA—thyroid cancer	0.000234	0.00115	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—RXRA—thyroid cancer	0.000228	0.00112	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MEN1—thyroid cancer	0.000225	0.0011	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000222	0.00109	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CDK1—thyroid cancer	0.000212	0.00104	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PTEN—thyroid cancer	0.00021	0.00103	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTCH1—thyroid cancer	0.000203	0.000998	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PTGS2—thyroid cancer	0.000203	0.000994	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SST—thyroid cancer	0.000186	0.000913	CbGpPWpGaD
Sulpiride—CA6—Metabolism—AKT1—thyroid cancer	0.000183	0.000896	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CALCA—thyroid cancer	0.000179	0.000879	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PTEN—thyroid cancer	0.000177	0.000867	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NRG1—thyroid cancer	0.00017	0.000835	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CDK1—thyroid cancer	0.000162	0.000796	CbGpPWpGaD
Sulpiride—CA12—Metabolism—AKT1—thyroid cancer	0.000158	0.000775	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TERT—thyroid cancer	0.000153	0.000749	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HIF1A—thyroid cancer	0.000146	0.000717	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PPARG—thyroid cancer	0.000144	0.000708	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NRG1—thyroid cancer	0.00013	0.000639	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—NRAS—thyroid cancer	0.000129	0.000631	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—BRAF—thyroid cancer	0.000121	0.000593	CbGpPWpGaD
Sulpiride—CA2—Metabolism—AKT1—thyroid cancer	0.000121	0.000593	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TERT—thyroid cancer	0.000117	0.000573	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PTGS2—thyroid cancer	0.000113	0.000557	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HIF1A—thyroid cancer	0.000112	0.000548	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—KRAS—thyroid cancer	0.000111	0.000543	CbGpPWpGaD
Sulpiride—CA9—Metabolism—AKT1—thyroid cancer	0.000102	0.000499	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PTEN—thyroid cancer	9.89e-05	0.000485	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—NRAS—thyroid cancer	9.85e-05	0.000483	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HRAS—thyroid cancer	9.41e-05	0.000462	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—BRAF—thyroid cancer	9.25e-05	0.000454	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	9.15e-05	0.000449	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CCND1—thyroid cancer	8.83e-05	0.000433	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTEN—thyroid cancer	8.52e-05	0.000418	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—KRAS—thyroid cancer	8.47e-05	0.000416	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—AKT1—thyroid cancer	8.31e-05	0.000408	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NRAS—thyroid cancer	7.6e-05	0.000373	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HRAS—thyroid cancer	7.2e-05	0.000353	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	7e-05	0.000344	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CCND1—thyroid cancer	6.75e-05	0.000331	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—KRAS—thyroid cancer	6.54e-05	0.000321	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTEN—thyroid cancer	6.52e-05	0.00032	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—AKT1—thyroid cancer	6.36e-05	0.000312	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NRAS—thyroid cancer	5.82e-05	0.000285	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TP53—thyroid cancer	5.81e-05	0.000285	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AKT1—thyroid cancer	5.7e-05	0.00028	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HRAS—thyroid cancer	5.56e-05	0.000273	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—KRAS—thyroid cancer	5.01e-05	0.000246	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKT1—thyroid cancer	4.91e-05	0.000241	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TP53—thyroid cancer	4.45e-05	0.000218	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HRAS—thyroid cancer	4.25e-05	0.000209	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKT1—thyroid cancer	3.76e-05	0.000184	CbGpPWpGaD
